Cystic Fibrosis

HomePatientsLung Disease Week at the ATS2015Cystic Fibrosis ▶ Information for Experts
Information for Experts

Cystic Fibrosis Week

 

ClinicianATS Educational Products

 

2015

D82

CHALLENGES AND CONSIDERATIONS IN THE MANAGEMENT OF PATIENTS WITH CYSTIC FIBROSIS: BEYOND ROUTINE CARE AND EXACERBATIONS

WS7

MANAGEMENT OF OLDER ADULTS WITH CYSTIC FIBROSIS

 

For more Best of ATS Conferences materials visit the following link https://store.thoracic.org or please contact Barbara Horner at bhorner@thoracic.org

 


 

ClinicianATS Journal articles on Cystic Fibrosis

 

AJRCCM

Regulation of IL-4 Receptor Signaling by STUB1 in Lung Inflammation
Vol. 189, No. 1 (2014), pp. 16-29
Read Abstract

Malfolded Protein Structure and Proteostasis in Lung Diseases
Vol. 189, No. 1 (2014), pp. 96-103
Read Abstract

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Vol. 187, No. 11 (2013), pp. 1219-1225
Read Abstract

Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial
Vol. 188, No. 1 (2013), pp. 83-89.
Read Abstract

A Clinical Prediction Tool for Prognosis in Patients with Cystic Fibrosis, Short-Term Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease, and Laryngeal Ultrasound for Prediction of Postextubation Laryngeal Edema
Vol. 189, No. 4 (2014), pp. 482-483.
Read Abstract

Lack of Neutrophil Elastase Reduces Inflammation, Mucus Hypersecretion, and Emphysema, but Not Mucus Obstruction, in Mice with Cystic Fibrosis–like Lung Disease
Vol. 189, No. 9 (2014), pp. 1082-1092.
Read Abstract

Measuring Mucociliary Transport and Mucus Properties in Multiple Regions of Airway Epithelial Surfaces Helps Clarify Cystic Fibrosis Defects
Vol. 190, No. 4 (2014), pp. 364-365.
Read Abstract

In Vivo X-Ray Imaging Reveals Improved Airway Surface Hydration after a Therapy Designed for Cystic Fibrosis
Vol. 190, No. 4(2014), pp. 469-472.
Read Abstract

Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease
Vol. 189, No. 8 (2014), pp. 956-965.
Read Abstract

 

AJRCMB

High Expression of Midkine in the Airways of Patients with Cystic Fibrosis
Vol. 49, No. 6 (2013), pp. 935-942
Read Abstract

Cystic Fibrosis Therapy: A Community Ecology Perspective
Vol. 48, No. 2 (2013), pp. 150-156
Read Abstract

Low Sphingosine-1–Phosphate Impairs Lung Dendritic Cells in Cystic Fibrosis
Vol. 48, No. 2 (2013), pp. 250-257
Read Abstract

H2O2 Stimulates Cystic Fibrosis Transmembrane Conductance Regulator through an Autocrine Prostaglandin Pathway, Using Multidrug-Resistant Protein–4
Vol. 49, No. 4 (2013), pp. 672-679
Read Abstract

Immune Responses in Cystic Fibrosis
Are They Intrinsically Defective?
Vol. 46, No. 6 (2012), pp. 715-722
Read Abstract

Activation of P2RY11 and ATP Release by Lipoxin A4 Restores the Airway Surface Liquid Layer and Epithelial Repair in Cystic Fibrosis
Vol. 51, No. 2 (2014), pp. 178-190.
Read Abstract

Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
Vol. 50, No. 4 (2014), pp. 805-816.
Read Abstract

A Genomic Signature Approach to Rescue ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator Biosynthesis and Function
Vol. 51, No. 3 (2014), pp. 354-362.
Read Abstract

 

AnnalsATS

What to Expect When You’re Expectorating: Cystic Fibrosis Exacerbations and Microbiota
Vol. 10, No.3 (2013), pp. 249-250
Read Abstract

Long-term Effects of Pregnancy and Motherhood on Disease Outcomes of Women with Cystic Fibrosis
Vol. 10, No. 3 (2013), pp. 213-219
Read Abstract

Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation
Vol. 10, No. 3 (2013), pp. 179-187
Read Abstract

Antibiotic Management of Lung Infections in Cystic Fibrosis. II. Nontuberculous Mycobacteria, Anaerobic Bacteria, and Fungi
Vol.11, (2014) pp. 1298-1306
Read Abstract

Quality Improvement Initiative to Reduce Deep Vein Thrombosis Associated with Peripherally Inserted Central Catheters in Adults with Cystic Fibrosis
Vol. 11, No. 9 (2014), pp. 1404-1410
Read Abstract

Cystic Fibrosis Foundation Pulmonary Guideline. Pharmacologic Approaches to Prevention and Eradication of Initial Pseudomonas aeruginosa Infection
Vol. 11, No. 10 (2014), pp. 1640-1650
Read Abstract

 


 

ClinicianATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. For examples, please Click Here.